These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3515662)

  • 1. The association of cytotoxic antidonor HLA antibodies and mismatched marrow graft rejection.
    Ting A; Pun A; Atkinson K; Dodds A; Biggs J
    Transplant Proc; 1986 Apr; 18(2):264-6. PubMed ID: 3515662
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
    Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH
    Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-HLA antibodies after rejection of HLA identical kidney transplants.
    Zafar MN; Terasaki PI; Naqvi SA; Rizvi SA
    Clin Transpl; 2006; ():421-6. PubMed ID: 18365399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of anti-donor antibodies in bone marrow transplant rejection: evaluation by flow cytometry and effect of plasma exchanges.
    Scornik JC; Elfenbein G; Graham-Pole J; Goedert T; Gross S; Weiner RS
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2974-5. PubMed ID: 2650407
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).
    Bishara A; Amar A; Brautbar C; Condiotti R; Lazarovitz V; Nagler A
    Exp Hematol; 1995 Dec; 23(14):1667-75. PubMed ID: 8542963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of donor-reactive cytotoxic antibodies following cardiac transplantation.
    Smith JD; Morgan AJ; Bravery C; Rose ML; Sachs JA; Yacoub MH
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1133-4. PubMed ID: 1989168
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of flow cytometric crossmatching in cardiac transplantation.
    Shenton BK; Glenville BE; Mitcheson AE; Coates E; Talbot D; Givan AL; Kirk A; Dark JH
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1153-4. PubMed ID: 1989175
    [No Abstract]   [Full Text] [Related]  

  • 9. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful engraftment in crossmatch-positive HLA-mismatched peripheral blood stem cell transplantation after depletion of antidonor cytotoxic HLA antibodies with rituximab and donor platelet infusion.
    Narimatsu H; Wake A; Miura Y; Tanaka H; Matsumura T; Takagi S; Kato D; Myojo T; Kusumi E; Masuoka K; Miyakoshi S; Morinaga S; Saji H; Ichinohe T; Taniguchi S
    Bone Marrow Transplant; 2005 Sep; 36(6):555-6. PubMed ID: 16007108
    [No Abstract]   [Full Text] [Related]  

  • 11. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytotoxic antibodies of HLA specificity after transplantation of the cornea].
    Gorgiladze TU; Shul'gina NS; Mitov TV
    Oftalmol Zh; 1985; (6):351-3. PubMed ID: 3906471
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of lymphocyte-mediated cytotoxicity (LMC) and antibody-dependent cell-mediated cytotoxicity (ADCC) with bone-marrow graft rejection in HLA-identical siblings.
    Warren RP; Storb R; Weiden PL; Su PJ; Thomas ED
    Transplant Proc; 1978 Jun; 10(2):433-4. PubMed ID: 354133
    [No Abstract]   [Full Text] [Related]  

  • 14. Transplantation of HLA-mismatched marrow depleted of T-cells by lectin agglutination and E-rosette depletion.
    O'Reilly RJ; Collins N; Dinsmore R; Kernan N; Siena S; Brochstein J; Kirkpatrick D; Flomenberg N; Shank B; Dupont B
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):99-107. PubMed ID: 3914748
    [No Abstract]   [Full Text] [Related]  

  • 15. Histocompatibility and other rejection risk factors in cardiac transplantation.
    Zerbe TR; Kormos R; Arena V; Griffith B; Hardesty R; Duquesnoy R
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1155-6. PubMed ID: 1989176
    [No Abstract]   [Full Text] [Related]  

  • 16. Value of plasma exchange in renal transplant rejection induced by specific anti-HLA antibodies.
    Vangelista A; Frascà GM; Nanni Costa A; Stefoni S; Bonomini V
    Trans Am Soc Artif Intern Organs; 1982; 28():599-603. PubMed ID: 6761939
    [No Abstract]   [Full Text] [Related]  

  • 17. Utility of posttransplantation panel-reactive antibody measurements for the prediction of rejection frequency and survival of heart transplant recipients.
    George JF; Kirklin JK; Shroyer TW; Naftel DC; Bourge RC; McGiffin DC; White-Williams C; Noreuil T
    J Heart Lung Transplant; 1995; 14(5):856-64. PubMed ID: 8800720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft failure in children receiving HLA-mismatched marrow transplants with busulfan-containing regimens.
    Schultz KR; Ratanatharathorn V; Abella E; Eisenbrey AB; Karanes C; Lum LG; de Planque MM; Uberti JP; Ravindranath Y; Sensenbrenner LL
    Bone Marrow Transplant; 1994 Jun; 13(6):817-22. PubMed ID: 7920320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor-specific HLA antibodies after transplantation are associated with deterioration in cardiac function.
    Leech SH; Mather PJ; Eisen HJ; Pina IL; Margulies KB; Bove AA; Jeevanandam V
    Clin Transplant; 1996 Dec; 10(6 Pt 2):639-45. PubMed ID: 8996758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor.
    Morishima Y; Yabe T; Matsuo K; Kashiwase K; Inoko H; Saji H; Yamamoto K; Maruya E; Akatsuka Y; Onizuka M; Sakamaki H; Sao H; Ogawa S; Kato S; Juji T; Sasazuki T; Kodera Y;
    Biol Blood Marrow Transplant; 2007 Mar; 13(3):315-28. PubMed ID: 17317585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.